BIOCRYST PHARMACEUTICALS INC filings

SEC filings by BIOCRYST PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14BAKER BROS. ADVISORS LPBIOCRYST PHARMACEUTICALS INC10,126,1764.9%EDGAR
SC 13G2024-02-14Avoro Capital Advisors LLCBIOCRYST PHARMACEUTICALS INC13,050,0006.4%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCBIOCRYST PHARMACEUTICALS INC17,763,7208.7%EDGAR
SC 13G/A2024-01-24STATE STREET CORPBIOCRYST PHARMACEUTICALS INC-6.2%EDGAR
SC 13G/A2024-01-24BlackRock Inc.BIOCRYST PHARMACEUTICALS INC18,681,3709.1%EDGAR
SC 13G/A2023-02-14BAKER BROS. ADVISORS LPBIOCRYST PHARMACEUTICALS INC19,106,8819.9%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCBIOCRYST PHARMACEUTICALS INC14,204,3957.6%EDGAR
SC 13G/A2023-02-06STATE STREET CORPBIOCRYST PHARMACEUTICALS INC-6.0%EDGAR
SC 13G/A2023-02-03BlackRock Inc.BIOCRYST PHARMACEUTICALS INC14,918,9558.0%EDGAR
SC 13G/A2022-02-14BAKER BROS. ADVISORS LPBIOCRYST PHARMACEUTICALS INC18,386,8319.9%EDGAR
SC 13G/A2022-02-09STATE STREET CORPBIOCRYST PHARMACEUTICALS INC-4.6%EDGAR
SC 13G/A2022-02-09VANGUARD GROUP INCBIOCRYST PHARMACEUTICALS INC9,412,9055.2%EDGAR
SC 13G/A2022-02-01BlackRock Inc.BIOCRYST PHARMACEUTICALS INC14,787,3958.2%EDGAR
SC 13G/A2021-04-12STATE STREET CORPBIOCRYST PHARMACEUTICALS INC-4.1%EDGAR
SC 13G/A2021-02-16Point72 Asset Management, L.P.BIOCRYST PHARMACEUTICALS INC3,230,8001.8%EDGAR
SC 13G/A2021-02-16CITADEL ADVISORS LLCBIOCRYST PHARMACEUTICALS INC-3.5%EDGAR
SC 13G/A2021-02-16BAKER BROS. ADVISORS LPBIOCRYST PHARMACEUTICALS INC18,100,96810.0%EDGAR
SC 13G/A2021-02-11JANUS HENDERSON GROUP PLCBIOCRYST PHARMACEUTICALS INC00.0%EDGAR
SC 13G/A2021-02-10VANGUARD GROUP INCBIOCRYST PHARMACEUTICALS INC11,599,3346.6%EDGAR
SC 13G/A2021-02-10INTEGRATED CORE STRATEGIES (US) LLCBIOCRYST PHARMACEUTICALS INC31,1300.0%EDGAR